Impact of pharmacist intervention on herpes zoster vaccination rates in patients with inflammatory disorders prescribed Janus Kinase inhibitors (JAKi)

被引：0
|
作者：
Barton, Marisa
Pope, Deborah
Harvey, Madelyn
Petitte, Morgan
机构：
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2024年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OPR47-EN
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 17 条
  • [1] Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination
    Galloway, J.
    Raine, T.
    Rivett, L.
    Roberts, J.
    Dews, S. -a.
    Choy, E. H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (07) : 1432 - 1441
  • [2] A Patient-Centered Approach to Increase Herpes Zoster Vaccination in Patients on Janus Kinase Inhibitors: A Fellowship Quality Improvement Initiative
    Dayno, Rachel
    Capponi, Sarah
    Song, Stephanie
    Bayefsky, Sarah
    Riley, Thomas
    Bean, Marta
    Oghene, John
    Kotzin, Jonathan
    Romich, Ellen
    Breslin-Perry, Paula
    Sandorfi, Nora
    Thomas, Preethi
    George, Michael
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2133 - 2135
  • [3] Effect of Janus kinase inhibitors on T cell responses to herpes zoster in rheumatoid arthritis patients
    Lee, J. -Y.
    Kim, S. H.
    Lee, S. -H.
    Kim, H. -R.
    Min, H. K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (05) : 1077 - 1087
  • [4] Influenza, Pneumococcal and Herpes Zoster Vaccination Rates in Patients with Autoimmune Inflammatory Rheumatic Diseases
    Krasselt, Marco
    Wagner, Ulf
    Seifert, Olga
    VACCINES, 2023, 11 (04)
  • [5] Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
    Kallmark, Hanna
    Bergstrom, Tomas
    Nagel, Johanna
    Gullstrand, Birgitta
    Einarsson, Jon T.
    Bengtsson, Anders A.
    Kapetanovic, Meliha C.
    RHEUMATOLOGY, 2023, : 2024 - 2033
  • [6] Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
    Kaellmark, Hanna
    Bergstroem, Tomas
    Nagel, Johanna
    Gullstrand, Birgitta
    Einarsson, Jon T.
    Bengtsson, Anders A.
    Kapetanovic, Meliha C.
    RHEUMATOLOGY, 2023, 63 (07) : 2024 - 2033
  • [7] Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders
    Wolfe, F.
    Michaud, K.
    Chakravarty, E. F.
    RHEUMATOLOGY, 2006, 45 (11) : 1370 - 1375
  • [8] Impact of Pre-Transplant Pharmacist Evaluations on Hepatitis B and Herpes Zoster Vaccination Rates in Solid Organ Transplant Recipients
    Ali, M.
    Dewy, K.
    Phillips, J.
    Quan, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S948 - S948
  • [9] Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study
    Chen, Po-Ku
    Chang, Shih-Hsin
    Chen, Yi-Ming
    Chen, Hsin-Hua
    Huang, Po-Hao
    Huang, Chien-Chung
    Yeo, Kai-Jieh
    Lan, Joung-Liang
    Chen, Der-Yuan
    CLINICAL RHEUMATOLOGY, 2024, 43 (08) : 2503 - 2511
  • [10] Immunogenicity of Adjuvanted Herpes Zoster Subunit Vaccine in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors and Controls: Preliminary Results
    Kallmark, Hanna
    Gullstrand, Birgitta
    Nagel, Johanna
    Einarsson, Jon
    Jonsson, Goran
    Kahn, Fredrik
    Kahn, Robin
    Bangtsson, Anders
    Bergstrom, Tomas
    Kapetanovic, Meliha
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12